keyword
felin
infecti
periton
diethylcarbamazin
immunomodul
drug
diethylcarbamazin
dec
long
use
treatment
filariasi
human
antiinfect
action
dec
filari
infect
attribut
immunomodul
previou
investig
suggest
one
possibl
mode
action
dec
opson
microfilaria
studi
show
dec
increas
adher
microfilaria
peripher
white
blood
cell
vitro
presenc
human
serum
contain
high
titr
antibodi
microfilari
sheath
although
recent
research
indic
kill
microfilaria
result
decinduc
plateletderiv
free
radic
also
evid
opson
activ
dec
may
promot
peripher
white
blood
cellantigen
interact
may
part
account
immun
respons
filari
antigen
note
success
dec
treatment
human
filariasi
dec
treatment
result
develop
serum
antibodi
felin
oncornavirusassoci
cell
membran
antigen
focma
nine
felvinfect
cat
previous
give
neg
result
antibodi
suggest
dec
might
increas
antibodi
titr
wide
varieti
infecti
agent
antibodi
focma
felvinfect
cat
associ
resist
felvrel
neoplasia
dec
treatment
given
felv
vaccin
result
increas
titr
durat
antibodi
focma
two
felvnaiv
cat
comparison
two
felvnaiv
cat
given
vaccin
without
dec
addit
dec
treatment
cat
household
exposur
felv
give
neg
result
felv
antigen
peripher
blood
leucocyt
result
increas
titr
antibodi
focma
cat
present
report
examin
effect
dec
treatment
serum
antibodi
felin
infecti
periton
fip
fip
caus
coronaviru
common
often
fatal
opportunist
infect
felvinfect
cat
approxim
clinic
evid
fip
infect
occur
felvinfect
cat
effect
dec
treatment
serum
antibodi
toxoplasmosi
rare
caus
clinic
diseas
felv
cat
also
investig
fourteen
cat
studi
seven
treat
dec
seven
untreat
group
seven
consist
three
felv
leucocyt
antigen
neg
cat
given
ml
leukocel
felv
vaccin
im
norden
laboratori
lincoln
ne
usa
four
felvinfect
cat
four
felvinfect
cat
gave
posit
result
felv
antigen
peripher
blood
leucocyt
determin
dr
wd
hardi
jr
cowork
laboratori
veterinari
oncolog
memori
sloankett
cancer
center
new
york
ny
usa
cat
test
felv
leucocyt
antigen
twice
week
serum
sampl
drawn
fip
antibodi
titr
detail
regard
mode
infect
felvinfect
cat
given
tabl
result
studi
regard
effect
dec
felv
infect
cat
describ
dec
given
oral
mg
kg
day
singl
daili
dose
cours
rang
week
continu
treatment
state
tabl
cat
hous
harvard
school
public
health
serum
sampl
drawn
dec
treatment
week
later
titr
serum
antibodi
felin
infecti
periton
toxoplasmosi
determin
code
via
indirect
dahlberg
strain
fip
rh
strain
toxoplasmosi
use
studi
cat
remain
healthi
throughout
studi
period
decuntr
group
serum
antibodi
titr
fip
increas
fourfold
two
felvinfect
cat
treat
group
three
cat
show
signific
rise
serum
antibodi
titr
fip
titr
increas
fourfold
two
treat
cat
one
cat
felvinfect
one
felvvaccinatedprevi
felvnaiv
serum
antibodi
fip
increas
repeat
ensur
accuraci
addit
dectreat
felvinfect
cat
furthermor
increas
serum
antibodi
titr
fip
note
dectreat
felvvaccin
cat
previous
felvnaiv
wherea
titr
increas
observ
decuntr
vaccin
control
see
tabl
thirteen
observ
cat
gave
neg
result
titr
serum
antibodi
toxoplasmosi
one
cat
give
posit
result
titr
toxoplasmosi
antibodi
treat
dec
titr
chang
treatment
data
may
reflect
lack
evid
activ
toxoplasmosi
infect
cat
adequ
titr
serum
antibodi
fip
prove
protect
cat
fip
infect
fiprel
diseas
howev
data
present
report
suggest
dec
treatment
result
higher
titr
serum
antibodi
nonretrovir
infecti
agent
fip
addit
retrovir
agent
felv
action
dec
could
exploit
vaccin
treatment
strategi
varieti
pathogen
infect
human
well
cat
anim
speci
addit
diagnos
activ
infect
base
rapid
strike
rise
serum
antibodi
titr
dec
therapi
ideal
support
pathogen
isol
conclus
clinic
sign
